StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BioCorRx's shares outstanding was 29M at Jun 30, 2026. For fiscal 2025 it was 18M, up 76.7% from the year before. Over ten years it grew 52.7% a year on average. The highest annual figure on record is 18M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202518M+76.7%
FY2024Dec 31, 202410M+288.0%
FY2023Dec 31, 20233M+86.3%
FY2022Dec 31, 20221M+37.2%
FY2021Dec 31, 20211M-7.5%
FY2020Dec 31, 20201M+0.5%
FY2019Dec 31, 20191M-53.3%
FY2018Dec 31, 20182M+33.8%
FY2017Dec 31, 20172M-27.4%
FY2016Dec 31, 20163M+833.8%
FY2015Dec 31, 20150M+49.0%
FY2014Dec 31, 20140M+13.8%
FY2013Dec 31, 20130M-85.1%
FY2012Dec 31, 20121M+110.0%
FY2011Dec 31, 20111M+36.6%
FY2010Dec 31, 20100M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202629M+71.8%
Q1 FY2026Mar 31, 202626M+69.6%
Q4 FY2025Dec 31, 202523M+82.7%
Q3 FY2025Sep 30, 202518M+66.5%
Q2 FY2025Jun 30, 202517M+455.7%
Q1 FY2025Mar 31, 202515M+413.3%
Q4 FY2024Dec 31, 202413M+222.6%
Q3 FY2024Sep 30, 202411M+276.2%
Q2 FY2024Jun 30, 20243M+42.5%
Q1 FY2024Mar 31, 20243M+63.5%
Q4 FY2023Dec 31, 20234M+267.7%
Q3 FY2023Sep 30, 20233M+185.3%
Q2 FY2023Jun 30, 20232M+89.9%
Q1 FY2023Mar 31, 20232M+58.7%
Q1 FY2022Mar 31, 20221M-80.1%
Q2 FY2021Sep 30, 20211M-81.1%
Q1 FY2021Mar 31, 20211M-0.4%
Q4 FY2020Dec 31, 20201M-1.2%
Q3 FY2020Sep 30, 20205M+74.7%
Q2 FY2020Jun 30, 20205M+76.0%
Q1 FY2020Mar 31, 20201M-53.2%
Q4 FY2019Dec 31, 20191M-13.3%
Q3 FY2019Sep 30, 20193M+23.4%
Q2 FY2019Jun 30, 20193M+21.7%
Q1 FY2019Mar 31, 20192M+34.6%
Q4 FY2018Dec 31, 20181M-27.1%
Q3 FY2018Sep 30, 20182M+3.0%
Q2 FY2018Jun 30, 20183M-56.8%
Q1 FY2018Mar 31, 20182M-49.3%
Q4 FY2017Dec 31, 20172M-60.1%
Q3 FY2017Sep 30, 20172M+43.7%
Q2 FY2017Jun 30, 20176M+250.5%
Q1 FY2017Mar 31, 20174M+1293.6%
Q4 FY2016Dec 31, 20165M+772.1%
Q3 FY2016Sep 30, 20162M–
Q2 FY2016Jun 30, 20162M–
Q1 FY2016Mar 31, 20160M–
Q4 FY2015Dec 31, 20151M–

More BioCorRx figures

See a number that looks wrong?